ARVN.NASDAQArvinas, INC

Form 4: Arvinas Director Laurie Smaldone Alsup Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


Laurie Smaldone Alsup, a director at Arvinas, Inc., reported the acquisition of restricted stock units and stock options on May 29, 2024.

Summary

  • On May 29, 2024, Laurie Smaldone Alsup, a director of Arvinas, Inc., was granted 5,899 restricted stock units (RSUs) and an option to purchase 9,070 shares of common stock.
  • The RSUs represent a contingent right to receive one share of Arvinas' common stock upon settlement for no consideration.
  • The RSUs and stock options vest in full on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
  • Following these transactions, Ms. Alsup beneficially owns 10,020 shares of Arvinas common stock and options to purchase 9,070 shares.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

  • The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment to the company's success.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

  • Stock option and RSU grants are a common form of compensation for directors in publicly traded companies, such as Arvinas.
  • The vesting schedules are typical, often tied to continued service or performance milestones, similar to practices at companies like Amgen and Gilead.

Stakeholder Impact

  • The stock and option awards align the director's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates

DateDescription
05/29/2024Date of transaction: grant of restricted stock units and stock options.
05/29/2025Vesting date for RSUs and stock options (or earlier if board meeting occurs after annual meeting).
05/28/2034Expiration date for the stock options.
05/31/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.